Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1255

1.

Post-operative complications increase the risk of long-term chronic kidney disease after nephron sparing surgery in renal cancer patients with normal preoperative renal function.

Ventimiglia E, Larcher A, Trevisani F, Muttin F, Cianflone F, Montorsi F, Salonia A, Bertini R, Capitanio U.

BJU Int. 2019 Feb 15. doi: 10.1111/bju.14712. [Epub ahead of print]

PMID:
30768877
2.

Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.

Mazzone E, Nazzani S, Knipper S, Tian Z, Preisser F, Gallina A, Soulières D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.

Eur J Surg Oncol. 2019 Feb 3. pii: S0748-7983(19)30244-6. doi: 10.1016/j.ejso.2019.01.218. [Epub ahead of print]

PMID:
30755341
3.

Medium term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using HIFU for primary localized prostate cancer.

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, Dickinson L, Allen C, Punwani S, Jameson C, Freeman A, McCartan N, Montorsi F, Briganti A, Ahmed HU, Emberton M, Moore CM.

BJU Int. 2019 Feb 12. doi: 10.1111/bju.14710. [Epub ahead of print]

PMID:
30753756
4.

The Impact Of Experience On The Risk Of Surgical Margins And Biochemical Recurrence After Robot-Assisted Radical Prostatectomy: A Learning-Curve Study.

Bravi CA, Tin A, Vertosick E, Mazzone E, Martini A, Dell'Oglio P, Stabile A, Gandaglia G, Fossati N, Suardi N, Gallina A, Briganti A, Montorsi F, Vickers A.

J Urol. 2019 Feb 7. doi: 10.1097/JU.0000000000000147. [Epub ahead of print]

PMID:
30747873
5.

MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?

Cristel G, Esposito A, Briganti A, Damascelli A, Brembilla G, Freschi M, Ambrosi A, Montorsi F, Del Maschio A, De Cobelli F.

Clin Radiol. 2019 Feb 7. pii: S0009-9260(19)30031-5. doi: 10.1016/j.crad.2018.08.017. [Epub ahead of print]

PMID:
30739715
6.

Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.

Hamilton ZA, Capitanio U, Lane BR, Larcher A, Yim K, Dey S, Cotta BH, Meagher MF, Kirmiz S, Bezinque A, Eldefrawy A, Bradshaw A, Ryan S, Carenzi C, Wan F, Proudfoot J, Montorsi F, Derweesh IH.

World J Urol. 2019 Feb 1. doi: 10.1007/s00345-019-02650-9. [Epub ahead of print]

PMID:
30710156
7.

The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy.

Capogrosso P, Larcher A, Nini A, Muttin F, Cianflone F, Ripa F, Briganti A, Necchi A, Montorsi F, Salonia A, Bertini R, Capitanio U.

Urol Oncol. 2019 Jan 28. pii: S1078-1439(19)30010-9. doi: 10.1016/j.urolonc.2019.01.009. [Epub ahead of print]

PMID:
30704958
8.

Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?

Moschini M, Zamboni S, Mattei A, Baumeister P, Di Bona C, Cornelius J, Shariat SF, Freschi M, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A; Ospedale San Raffaele.

Urol Int. 2019 Jan 29:1-8. doi: 10.1159/000493899. [Epub ahead of print]

PMID:
30695782
9.

On Having Grey Hair.

Montorsi F.

Eur Urol. 2019 Jan 22. pii: S0302-2838(19)30003-X. doi: 10.1016/j.eururo.2019.01.002. [Epub ahead of print]

PMID:
30683573
10.

Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic resonance imaging.

Martini A, Gupta A, Cumarasamy S, Lewis SC, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK.

Int J Urol. 2019 Jan 18. doi: 10.1111/iju.13905. [Epub ahead of print]

PMID:
30659663
11.

Cytoreductive nephrectomy is dead, long live cytoreductive nephrectomy.

Capitanio U, Larcher A, Montorsi F.

BJU Int. 2019 Jan 17. doi: 10.1111/bju.14675. [Epub ahead of print] No abstract available.

PMID:
30656818
12.

Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience.

Ciriaco P, Briganti A, Bernabei A, Gandaglia G, Carretta A, Viola C, Montorsi F, Negri G.

Eur Urol. 2019 Jan 4. pii: S0302-2838(18)31035-2. doi: 10.1016/j.eururo.2018.12.029. [Epub ahead of print]

PMID:
30616951
13.

Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study.

Preisser F, Mazzone E, Nazzani S, Knipper S, Tian Z, Mandel P, Pompe R, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 Dec 26. pii: S2405-4569(18)30405-X. doi: 10.1016/j.euf.2018.12.006. [Epub ahead of print]

PMID:
30594487
14.

Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.

Bianchi L, Gandaglia G, Fossati N, Larcher A, Pultrone C, Turri F, Selli C, de Groote R, de Naeyer G, Borghesi M, Schiavina R, Brunocilla E, Briganti A, Montorsi F, Mottrie A.

Minerva Urol Nefrol. 2019 Feb;71(1):38-46. doi: 10.23736/S0393-2249.18.03285-X. Epub 2018 Dec 14.

PMID:
30547906
15.

Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology.

Villa L, Capogrosso P, Capitanio U, Martini A, Briganti A, Salonia A, Montorsi F.

Adv Ther. 2019 Jan;36(1):1-18. doi: 10.1007/s12325-018-0854-2. Epub 2018 Dec 6. Review.

PMID:
30523608
16.

Reply from Authors re: Jens. J. Rassweiler, Marcel Fiedler-Hruza. The Learning Curve for Robot-assisted Partial Nephrectomy: There is Much Beyond a Trifecta. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.022: The Clinical Implications of Surgical Learning Curve Analysis: Can We Optimize Patient Outcomes Using Structured Training Programs?

Larcher A, Muttin F, Baiamonte G, Peyronnet B, De Naeyer G, Khene ZE, Dell'Oglio P, Ferreiro C, Schatteman P, Capitanio U, D'Hondt F, Montorsi F, Bensalah K, Mottrie A.

Eur Urol. 2019 Feb;75(2):259-260. doi: 10.1016/j.eururo.2018.11.020. Epub 2018 Dec 4. No abstract available.

PMID:
30522913
17.

Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?

Mazzone E, Knipper S, Mistretta FA, Tian Z, Preisser F, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.

Cancer Epidemiol. 2019 Feb;58:83-88. doi: 10.1016/j.canep.2018.11.007. Epub 2018 Dec 6.

PMID:
30528834
18.

More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.

Mazzone E, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Nov 17. pii: S1558-7673(18)30678-5. doi: 10.1016/j.clgc.2018.11.003. [Epub ahead of print]

PMID:
30527745
19.

Intratunical Injection of Human Adipose Tissue-Derived Stem Cells Restores Collagen III/I Ratio in a Rat Model of Chronic Peyronie's Disease.

Castiglione F, Hedlund P, Weyne E, Hakim L, Montorsi F, Bivalacqua TJ, De Ridder D, Milenkovic U, Ralph D, Garaffa G, Muneer A, Joniau S, Albersen M; Trauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists.

Sex Med. 2019 Mar;7(1):94-103. doi: 10.1016/j.esxm.2018.09.003. Epub 2018 Nov 30.

20.

High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men.

Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Cazzaniga W, Chierigo F, Pozzi E, Clementi M, Viganò P, Montanari E, Montorsi F, Salonia A.

Hum Reprod. 2019 Feb 1;34(2):209-217. doi: 10.1093/humrep/dey348.

PMID:
30517657

Supplemental Content

Loading ...
Support Center